Micar Innovation (Micar21) received award: "Investor of the year 2018" Success Startup.

7 March 2019

Micar Innovation (Micar21) received award: "Investor of the year 2018" Success Startup - InvestBulgaria Agency part of Bulgarian Ministry of Economy.

Deputy Minister of Ministry of Economy of the Republic of Bulgaria Mr. Borisov handed award: "Investor of the year 2018" Success Startup to Dimitar Dimitrov

InvestBulgaria Agency (IBA) is a government organization, established to attract investment to Bulgaria, to assist project set-up and to ensure successful project development resulting in new jobs, exports and know-how transfer for the Bulgarian economy. We help potential and existing investors explore the investment opportunities in Bulgaria and carry out greenfield investment projects in the country. Our agency reports directly to the Bulgarian Ministry of Economy. As a government institution, we have direct access to all Bulgarian government and local institutions to facilitate the entry and development of your business in the country.

Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through new blockbuster drug molecules for a large class of diseases. Micar Innovation focuses on non-clinical Proof-of-Concepts (POCs) in preclinical R&D and Hit-to-Lead (H2L) achievements in areas such as neuroscience, oncology, cardio-vascularity, dermatology, rare diseases. Micar21 is our drug discovery platform for small molecule drug candidates. The business model is based on licensing our intellectual property to commercial partners and on the creation new spin out companies.

Micar Innovation (Micar21) received the Excellence in Innovation label 2018 Bulgaria

8 February 2019

The Excellence in Innovation label of the Applied Research and Communications Fund. The label is provided for the use of enterprises that have successfully passed the evaluation by the ARC Fund and jury experts within the framework of the Innovative Enterprise of the year Contest. Criteria for evaluation to grant the label use include high quality and originality of innovations, impacts on national and world markets, environment and society, efficiency of the business model.

The President of the Republic of Bulgaria Mr. Rumen Radev handed Excellence in Innovation label to Filip Fratev.

Source: Applied Research and Communications Fund

Source: Applied Research and Communications Fund

Source: Applied Research and Communications Fund

Source: Applied Research and Communications Fund

Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through new blockbuster drug molecules for a large class of diseases. Micar Innovation focuses on non-clinical Proof-of-Concepts (POCs) in preclinical R&D and Hit-to-Lead (H2L) achievements in areas such as neuroscience, oncology, cardio-vascularity, dermatology, rare diseases. Micar21 is our drug discovery platform for small molecule drug candidates. The business model is based on licensing our intellectual property to commercial partners and on the creation new spin out companies.

Micar Innovation (Micar21) is the winner of а prestigious award for Innovative startup enterprise of the year 2018

6 December 2018

The National Competition “Innovative Enterprise of the Year” annually awards Bulgarian enterprises with successfully implemented innovative products, processes, services and practices on the Bulgarian and world markets.

Тhe 14th edition of the competition “Innovative Enterprise of the Year – 2018” took place during the National Innovation Forum on 6 December 2018.

The Forum with the participation of the President of the Republic of Bulgaria Mr. Rumen Radev features the award ceremony of the Innovative Enterprise of the Year 2018 national contest..

For Innovative New Startup Enterprise, Micar Innovation (Micar21) was awarded an honorary certificate.

Source: Enterprise Europe Network

Source: Applied Research and Communications Fund

Source: Applied Research and Communications Fund

Source: Applied Research and Communications Fund

About Innovative Enterprise of the Year – 2018 - more information: Innovative Enterprise of the Year – 2018

Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through new blockbuster drug molecules for a large class of diseases. Micar Innovation focuses on non-clinical Proof-of-Concepts (POCs) in preclinical R&D and Hit-to-Lead (H2L) achievements in areas such as neuroscience, oncology, cardio-vascularity, dermatology, rare diseases. Micar21 is our drug discovery platform for small molecule drug candidates. The business model is based on licensing our intellectual property to commercial partners and on the creation new spin out companies.

“European CIDIC Award”

24 April 2018

Micar Innovation (Micar21) has been awarded a “European CIDIC Award”

We are delighted to introduce DEAC (Diplomatic, Economic, Academic and Cultural) days concept organised during each bi-annual presidency of the Council of the EU which is currently BULGARIA.

The CIDIC jury, composed of its board of directors, professors of the Vrij Universiteit Brussel (VUB), representatives of the Bulgarian Embassy in Brussels, is pleased to inform that Micar Innovation (Micar21) has been awarded a “European CIDIC Award”.

This Award has handed over at the BCCI during our DEAC days in Sofia and you are cordially invited to collect yours during the ceremony followed by a reception organised by the Belgian Ambassador in his residence on TUESDAY 24th APRIL 2018 from 16:30

Micar Innovation received the CIDIC award for its well-chosen positioning in a complex and long value chain, where it can create key-value contributions by delivering non-clinical POCs. The company can be qualified as a fountain of intellectual property and an IP broker for new pharma startups and big pharma industry.

About CIDIC: CIDIC is the European Centre of Economic Diplomacy and addresses the Diplomatic, Economic, Academic and Cultural world. CIDIC facilitates meetings between the actors of these worlds to promote, in an informal way, privileged relationships. CIDIC fosters improved awareness and common activities among decision-makers in these different spheres through DEAC Missions (Diplomatic-Economic-Academic-Cultural) to the countries presiding the Council of the European Union on a rotating basis, thematic conferences and receptions. CIDIC is supported by UNICA (Network of Universities from the Capitals of Europe), the Brussels Diplomatic Academy, the Diplomatic World Magazine and the Belgian Ministry of Foreign Affairs. Baron Ernest de Laminne de Bex ( President) - more information: www.cidic.be

Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through new blockbuster drug molecules for a large class of diseases. Micar Innovation focuses on non-clinical Proof-of-Concepts (POCs) in preclinical R&D and Hit-to-Lead (H2L) achievements in areas such as neuroscience, oncology, cardio-vascularity, dermatology, rare diseases. Micar21 is our drug discovery platform for small molecule drug candidates. The business model is based on licensing our intellectual property to commercial partners and on the creation new spin out companies.

Micar Innovation received the CIDIC award for its well-chosen positioning in a complex and long value chain, where it can create key-value contributions by delivering non-clinical POCs. The company can be qualified as a fountain of intellectual property and an IP broker for new pharma startups and big pharma industry.